
GenScript Life Science Group is a part of GenScript Biotech Corporation. Founded in 2002 in New Jersey, GenScript Biotech Corporation accelerates innovation in biotech and healthcare by providing researchers and companies with the building blocks needed to develop ground breaking treatments and products. As a cornerstone of the global life science ecosystem, GenScript actively collaborates with a diverse network of partners—from academic institutions to industry leaders—to co-create cutting-edge solutions that redefine service excellence. Guided by its mission to Make People and Nature Healthier Through Biotechnology, and its role as a well-recognized biotechnology company, GenScript has become a trusted global partner with a team of approximately 6,165 employees, supporting over 200,000 customers across 100+ countries and regions, including the world’s Top 20 pharma companies.
Unlock the market timeline & signal feed
New Partnerships activity — 1 fresh signal just appeared.
The order this company entered each market — oldest to newest
20 active postings
Biotechnologist (Gene)
Sign up to see the full signal feed
How GenScript's international expansion compares to its competitors
Bars show relative size across the companies compared.
Columns5| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
GenScriptYou | 7 | 2 | -55% | 58 | 38 |
QA Engineer (Onsite)
View postingSingapore, Singapore · yesterday
Biotechnologist (Gene-Trouble Shooting & Order Management)
View postingSingapore, Singapore · 2d ago
Lean Specialist
View postingPiscataway, NJ · 5d ago
The 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
EndedThe 𝗧𝘂𝗿𝗯𝗼𝗖𝗛𝗢™ 𝗣𝗿𝗼𝘁𝗲𝗶𝗻 𝗘𝘅𝗽𝗿𝗲𝘀𝘀𝗶𝗼𝗻 𝗞𝗶𝘁 is designed to accelerate antibody and recombinant protein production with strong, consistent performance across formats.Built on next-generation CHO expression technology, TurboCHO™ helps streamline early-stage discovery workflows while maintaining high yield and reliability.Key performance highlights:⏱️ Compared to existing products on the market, the kit achieves 𝗵𝗶𝗴𝗵𝗲𝗿 𝘁𝗶𝘁𝗲𝗿𝘀 𝗶𝗻 𝗷𝘂𝘀𝘁 𝗵𝗮𝗹𝗳 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, ...
EndedOlvídate de inconsistencias entre lotes: expresa proteínas de forma automatizada.
EndedGenScript opens mRNA facility in Delft, Netherlands, expanding global R&D network and strengthening European biotech infrastructure.
GenScript offers high-efficiency nucleic acid synthesis equipment with 99.5%+ coupling efficiency, covering micro to industrial-scale production for life sciences and biopharmaceutical research.
GenScript Biotech reports 81.9% revenue growth to $518.8M in H1 2025, with 509.6% increase in adjusted net profit to $178M, driven by global expansion and innovation across all business segments.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about GenScript's business, markets, and growth signals.

© 2026 Pubrio. All rights reserved.